Gedeon Richter

Gedeon Richter Plc. is a prominent European multinational pharmaceutical and biotechnology company, established in Budapest, Hungary, in 1901. As the largest pharmaceutical entity in Central and Eastern Europe, it has cultivated a significant global footprint. The company operates with a substantial workforce, exceeding 10,000 employees, and maintains the largest Research and Development unit in its primary region. Its strategic expansion includes direct operations across Western Europe, China, North America, and Latin America, contributing to its presence in over 50 countries worldwide. Gedeon Richter is dedicated to innovation and quality in healthcare solutions.

The company's operational scope is extensive, encompassing diverse therapeutic areas. Key focus areas include treatments for the central nervous system, women's health, and cardiovascular conditions, alongside active development in biosimilar products. Gedeon Richter is committed to advancing human health through its scientific endeavors and manufacturing capabilities. To learn more about the people driving these advancements, you can Meet Gedeon Richter's team and discover their expertise.

With a robust revenue of $3.9 billion, Gedeon Richter demonstrates significant market strength. The company is publicly traded, holding a primary listing on the Budapest Stock Exchange, where it is a constituent of the BUX Index, and also maintains secondary listings on the Luxembourg Stock Exchange. Its long-standing history, dating back to its founding pharmacist Gedeon Richter, underscores its enduring commitment to pharmaceutical excellence and innovation in the global healthcare landscape.